Table 4.
(CIP–Ca)2+ | (CIP–Cu)2+ | CIP solution | |
---|---|---|---|
Ka (M−1) (from [31]) | 100 | 906,900 | |
Concentration (µM) needed to reduce the CIP Papp by 50% (from [31]) | 40 | 0.04 | |
ELF Cmax (µg/mL) after IT administration to rats (from [22]) | 26.5 ± 17.7 | 142.3 ± 81.5 | 1.0 ± 0.4 |
CIP AUCELF to AUCplasma ratio after IT administration to rats (from [22]) | 203 | 1069 | 9.8 |